13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001920938
申报总市值
US$27.0亿
US$27.0亿
55 檔
31.4%
截至 Q2 2025 季度末，Braidwell LP 的美股持仓估值约为 US$27.0亿，全数申报仓位共有 55 档。
在 Q2 2025，Braidwell LP 展现出较为审慎的避险与获利了结姿态。本季共减仓 19 个仓位并完全清仓 16 档持股，调降曝光的仓位数量高于加仓动作。
在资产配置集中度方面，Braidwell LP 的前 5 大核心持股（包含 GH 1.25 02-15-31, CAI, NBIX 等）合计占整体申报市值的 31.4%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GH 1.25 02-15-31债券 | Guardant Health Inc | 债券 | 8.77% | -3.42% | EXIT | |
| 2 | CAI | Caris Life Sciences Inc | 股票-其他 | 6.69% | +0.66% | — | |
| 3 | NBIX | Neurocrine Biosciences Inc | 股票-医疗保健 | 4.99% | -0.77% | -2.64% | |
| 4 | NVCR 0 11-01-25债券 | Novocure LTD | 债券 | 4.71% | — | — | |
| 5 | XENE | Xenon Pharmaceuticals Inc | 股票-其他 | 3.86% | -0.07% | +33.03% | |
| 6 | ARGX | Argenx Se - Adr | 股票-医疗保健 | 3.67% | -1.46% | +20.92% | |
| 7 | RGEN 1 12-15-28债券 | Repligen CORP | 债券 | 3.44% | -2.68% | +3.06% | |
| 8 | KRYS | Krystal Biotech Inc | 股票-医疗保健 | 3.42% | +0.20% | +81.61% | |
| 9 | ALGN | Align Technology Inc | 股票-医疗保健 | 3.22% | — | -6.37% | |
| 10 | LEGN | Legend Biotech Corp-adr | 股票-其他 | 3.09% | — | -14.64% | |
| 11 | IRTC 1.5 09-01-29债券 | Irhythm Holdings Inc | 债券 | 3.08% | — | -18.60% | |
| 12 | NUVL | Nuvalent Inc-a | 股票-其他 | 3.07% | -2.39% | EXIT | |
| 13 | NEO 0.25 01-15-28债券 | Neogenomics Inc | 债券 | 2.98% | -2.44% | — | |
| 14 | CGON | Cg Oncology Inc | 股票-其他 | 2.92% | -2.22% | EXIT | |
| 15 | IRWD 1.5 06-15-26债券 | Ironwood Pharmaceuticals | 债券 | 2.68% | — | — | |
| 16 | EWTX | Edgewise Therapeutics Inc | 股票-其他 | 2.34% | +0.53% | +111.93% | |
| 17 | INSP | Inspire Medical Systems Inc | 股票-医疗保健 | 2.32% | -0.05% | +72.75% | |
| 18 | APGE | Apogee Therapeutics Inc | 股票-其他 | 2.20% | -1.34% | EXIT | |
| 19 | GKOS | Glaukos CORP | 股票-医疗保健 | 2.13% | +0.32% | -3.37% | |
| 20 | DHR | Danaher CORP | 股票-医疗保健 | 2.09% | +0.18% | — | |
| 21 | TMO | Thermo Fisher Scientific Inc | 股票-医疗保健 | 1.88% | +0.14% | +5.87% | |
| 22 | ISRG | Intuitive Surgical Inc | 股票-医疗保健 | 1.67% | -0.16% | +1.82% | |
| 23 | IRTC | Irhythm Holdings Inc | 股票-医疗保健 | 1.58% | +0.48% | -46.08% | |
| 24 | ADPT | Adaptive Biotechnologies | 股票-其他 | 1.54% | — | -19.58% | |
| 25 | GH | Guardant Health Inc | 股票-医疗保健 | 1.49% | -0.72% | -36.88% | |
| 26 | ATEC | Alphatec Holdings Inc | 股票-其他 | 1.38% | +1.30% | -14.66% | |
| 27 | SYRE | Spyre Therapeutics Inc | 股票-其他 | 1.32% | +1.32% | — | |
| 28 | VKTX | Viking Therapeutics Inc | 股票-医疗保健 | 1.30% | — | +0.11% | |
| 29 | KPTI 6 05-13-29 *债券 | Karyopharm Therapeutics | 债券 | 1.22% | — | — | |
| 30 | TMDX | Transmedics Group Inc | 股票-医疗保健 | 1.17% | +0.41% | -70.17% | |
| 31 | PEN | Penumbra Inc | 股票-医疗保健 | 1.14% | -1.15% | EXIT | |
| 32 | DYN | Dyne Therapeutics Inc | 股票-其他 | 1.07% | -0.26% | -9.61% | |
| 33 | KNSA | Kiniksa Pharmaceuticals International, plc | 股票-其他 | 1.04% | -0.01% | -43.83% | |
| 34 | HROW | Harrow Inc | 股票-其他 | 0.91% | -0.18% | EXIT | |
| 35 | KIDS | Orthopediatrics CORP | 股票-其他 | 0.81% | +0.20% | — | |
| 36 | IMCR 2.5 02-01-30债券 | Immunocore Holdings | 债券 | 0.80% | — | -48.24% | |
| 37 | MRVI | Maravai Lifesciences Hldgs-a | 股票-其他 | 0.69% | +1.04% | — | |
| 38 | APLSUSD | Apellis Pharmaceuticals Inc | 股票-其他 | 0.66% | — | -32.15% | |
| 39 | SION | Sionna Therapeutics Inc | 股票-其他 | 0.64% | — | — | |
| 40 | MDGL | Madrigal Pharmaceuticals Inc | 股票-医疗保健 | 0.63% | — | +24.83% | |
| 41 | DXCM 0.25 11-15-25债券 | Dexcom Inc | 债券 | 0.62% | — | — | |
| 42 | RGEN | Repligen CORP | 股票-医疗保健 | 0.61% | +0.70% | +77.03% | |
| 43 | ORKA | Oruka Therapeutics Inc | 股票-其他 | 0.58% | +0.98% | NEW | |
| 44 | CSTL | Castle Biosciences Inc | 股票-其他 | 0.57% | — | +125.25% | |
| 45 | UNH | Unitedhealth Group Inc | 股票-医疗保健 | 0.53% | — | — | |
| 46 | GMED | Globus Medical Inc - A | 股票-医疗保健 | 0.50% | — | — | |
| 47 | DAWNGBX | Day One Biopharmaceuticals I | 股票-其他 | 0.48% | — | -38.32% | |
| 48 | XNCR | Xencor Inc | 股票-其他 | 0.45% | — | — | |
| 49 | CELC | Celcuity Inc | 股票-其他 | 0.40% | -0.11% | EXIT | |
| 50 | ATEC 0.75 08-01-26债券 | Alphatec Holdings Inc | 债券 | 0.20% | — | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | CAI | Caris Life Sciences Inc | +6.7% | NEW | 新建仓 |
| 2 | KPTI 6 05-13-29 *债券 | Karyopharm Therapeutics | +1.2% | NEW | 新建仓 |
| 3 | NUVL | Nuvalent Inc-a | +1% | +39.83% | 加仓 |
| 4 | KRYS | Krystal Biotech Inc | +0.9% | +81.61% | 加仓 |
| 5 | GH 1.25 02-15-31债券 | Guardant Health Inc | +0.8% | — | 不变 |
| 6 | XENE | Xenon Pharmaceuticals Inc | +0.7% | +33.03% | 加仓 |
| 7 | SION | Sionna Therapeutics Inc | +0.6% | NEW | 新建仓 |
| 8 | INSP | Inspire Medical Systems Inc | +0.6% | +72.75% | 加仓 |
| 9 | UNH | Unitedhealth Group Inc | +0.5% | NEW | 新建仓 |
| 10 | GMED | Globus Medical Inc - A | +0.5% | NEW | 新建仓 |
| 11 | EWTX | Edgewise Therapeutics Inc | +0.4% | +111.93% | 加仓 |
| 12 | NBIX | Neurocrine Biosciences Inc | +0.4% | -2.64% | 减仓 |
| 13 | ARGX | Argenx Se - Adr | +0.3% | +20.92% | 加仓 |
| 14 | CSTL | Castle Biosciences Inc | +0.3% | +125.25% | 加仓 |
| 15 | ADPT | Adaptive Biotechnologies | +0.3% | -19.58% | 减仓 |
| 16 | ALGN | Align Technology Inc | +0.3% | -6.37% | 减仓 |
| 17 | RGEN | Repligen CORP | +0.2% | +77.03% | 加仓 |
| 18 | APGE | Apogee Therapeutics Inc | +0.2% | -4.02% | 减仓 |
| 19 | ISRG | Intuitive Surgical Inc | +0.1% | +1.82% | 加仓 |
| 20 | ✓ | Crescent Biopharma Inc. | +0.1% | NEW | 新建仓 |
| 21 | PEN | Penumbra Inc | +0.1% | +17.71% | 加仓 |
| 22 | CGON | Cg Oncology Inc | +0.1% | — | 不变 |
| 23 | CELC | Celcuity Inc | +0.1% | — | 不变 |
| 24 | VKTX | Viking Therapeutics Inc | +0.1% | +0.11% | 加仓 |
| 25 | RGEN 1 12-15-28债券 | Repligen CORP | +0.1% | +3.06% | 加仓 |
| 26 | MDGL | Madrigal Pharmaceuticals Inc | +0.1% | +24.83% | 加仓 |
| 27 | MRVI | Maravai Lifesciences Hldgs-a | 0% | — | 不变 |
| 28 | SRZN | Surrozen Inc | 0% | NEW | 新建仓 |
| 29 | HROW | Harrow Inc | 0% | -8.84% | 减仓 |
| 30 | ORKA | Oruka Therapeutics Inc | 0% | -3.03% | 减仓 |
| 31 | ATEC 0.75 08-01-26债券 | Alphatec Holdings Inc | — | — | 不变 |
| 32 | DXCM 0.25 11-15-25债券 | Dexcom Inc | 0% | — | 不变 |
| 33 | ✓ | Zura Bio LTD | 0% | — | 不变 |
| 34 | TRVI | Trevi Therapeutics Inc | 0% | EXIT | 清仓 |
| 35 | GKOS | Glaukos CORP | 0% | -3.37% | 减仓 |
| 36 | SKYE | Skye Bioscience Inc | -0.1% | EXIT | 清仓 |
| 37 | BBNX | Beta Bionics Inc | -0.1% | EXIT | 清仓 |
| 38 | IRTC 1.5 09-01-29债券 | Irhythm Holdings Inc | -0.1% | -18.60% | 减仓 |
| 39 | NVCR 0 11-01-25债券 | Novocure LTD | -0.1% | — | 不变 |
| 40 | LUNG | Pulmonx CORP | -0.1% | — | 不变 |
| 41 | NEO 0.25 01-15-28债券 | Neogenomics Inc | -0.1% | — | 不变 |
| 42 | AARD | Aardvark Therapeutics Inc | -0.1% | EXIT | 清仓 |
| 43 | ✓ | -0.1% | EXIT | 清仓 | |
| 44 | SYRE | Spyre Therapeutics Inc | -0.1% | — | 不变 |
| 45 | ATEC | Alphatec Holdings Inc | -0.1% | -14.66% | 减仓 |
| 46 | DHR | Danaher CORP | -0.1% | — | 不变 |
| 47 | KIDS | Orthopediatrics CORP | -0.2% | — | 不变 |
| 48 | ✓ | -0.2% | EXIT | 清仓 | |
| 49 | XNCR | Xencor Inc | -0.2% | — | 不变 |
| 50 | IRWD 1.5 06-15-26债券 | Ironwood Pharmaceuticals | -0.2% | — | 不变 |
根据 SEC 官方 Form 13F 申报备案，Braidwell LP 在 Q2 2025 季度的美股持仓总市值约为 US$27.0亿，共申报了 55 个公开持股仓位。
在 Q2 2025 季度，Braidwell LP 按市值排列的前三大核心持股分别为：GH 1.25 02-15-31 (8.8%)、CAI (6.7%)、NBIX (5.0%)。其中最大持股仓位 GH 1.25 02-15-31 占据整体投资组合约 8.8% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
CAI
市值: US$2.0亿
本季最大获利了结 / 清仓标的
BBIO 2.5 03-15-27
前期市值: US$7199.7万
在 Q2 2025 季度中，Braidwell LP 共进行了 56 项持仓异动，包含新建仓 7 个仓位、加仓 14 个仓位、减仓 19 个仓位以及清仓 16 个仓位。 其中最大新建仓标的为 CAI。 本季清仓仓位包含 BBIO 2.5 03-15-27。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。